11.27
price down icon1.05%   -0.12
after-market Dopo l'orario di chiusura: 11.27
loading

Roivant Sciences Ltd Borsa (ROIV) Ultime notizie

pulisher
Jun 18, 2025

HC Wainwright & Co. Reiterates Buy Rating for Roivant Sciences (ROIV) | ROIV Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Cantor Fitzgerald reiterates overweight rating on Roivant Sciences stock By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

H.C. Wainwright reiterates buy rating on Roivant Sciences stock By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Guggenheim maintains buy rating on Roivant Sciences stock amid DM study - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

JPMorgan Maintains Positive Outlook on Roivant Sciences (ROIV) | ROIV Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

Roivant (ROIV) Hosts Investor Webinar on Brepocitinib's Role in Dermatomyositis | ROIV Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Long Term Trading Analysis for (ROIV) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 16, 2025

Roivant (ROIV) Publishes Promising Phase 1 Results for Inhaled M - GuruFocus

Jun 16, 2025
pulisher
Jun 10, 2025

Roivant Sciences at Goldman Sachs Conference: Strategic Execution Focus By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

Roivant Sciences at Goldman Sachs Conference: Strategic Execution Focus - Investing.com Australia

Jun 10, 2025
pulisher
Jun 09, 2025

Roivant and Priovant to Host Investor Video Conference at 1:00 PM ET on Tuesday, June 17 on Brepocitinib and the Unmet Medical Need in Dermatomyositis - Yahoo Finance

Jun 09, 2025
pulisher
Jun 07, 2025

Major Shareholder Cashes Out Millions in Roivant Sciences Stock - TipRanks

Jun 07, 2025
pulisher
Jun 04, 2025

(ROIV) Trading Advice - news.stocktradersdaily.com

Jun 04, 2025
pulisher
May 31, 2025

Vivek Ramaswamy’s firm wants to buy biotech companies to bet on bitcoin - MSN

May 31, 2025
pulisher
May 31, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $324,000 Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World

May 31, 2025
pulisher
May 31, 2025

Roivant Sciences Earnings Call: Balancing Growth and Challenges - MSN

May 31, 2025
pulisher
May 30, 2025

Roivant outlines packed 36-month launch and data cycle with under $5B cash reserve and multi-blockbuster pipeline - MSN

May 30, 2025
pulisher
May 30, 2025

Decoding Roivant Sciences Ltd (ROIV): A Strategic SWOT Insight - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Full Year 2025 Earnings: EPS Beats Expectations, Revenues Lag - simplywall.st

May 30, 2025
pulisher
May 30, 2025

While Wall Street Naps, These 10 Stocks Run Wild - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Why Roivant Sciences Ltd. (ROIV) Surged On Thursday - Insider Monkey

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Ltd (ROIV) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... By GuruFocus - Investing.com Canada

May 30, 2025
pulisher
May 30, 2025

Roivant Sciences Reports Progress and Financial Results - TipRanks

May 30, 2025
pulisher
May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm - The Malaysian Reserve

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates - MSN

May 29, 2025
pulisher
May 29, 2025

IMVT INVESTIGATION ALERT: Investigation Launched into Private Placement Transaction by Immunovant, Inc. and Attorneys Encourage Investors to Contact Law Firm – Company AnnouncementFT.com - Financial Times

May 29, 2025
pulisher
May 29, 2025

ROIV Crosses Above Key Moving Average Level - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences earnings missed by $0.03, revenue fell short of estimates - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Q4 2025 Earnings Call Transcript - MarketBeat

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences (ROIV) Stock Jumps Nearly 5%: What’s Fueling This Biotech Rally? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Transcript : Roivant Sciences Ltd., Q4 2025 Earnings Call, May 29, 2025 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Ltd reports results for the quarter ended March 31Earnings Summary - TradingView

May 29, 2025
pulisher
May 29, 2025

Tranche Update on Roivant Sciences Ltd.'s Equity Buyback Plan announced on April 2, 2024. - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Ltd. Reports Q4 and FY 2025 Financial Results - TradingView

May 29, 2025
pulisher
May 29, 2025

Roivant (ROIV) Reports Decrease in Q4 Revenue but Highlights Strategic Progress | ROIV Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences Fiscal Q4 Net Loss Widens, Revenue Falls - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Earnings Flash (IMVT) IMMUNOVANT INC. Reports Q4 Loss $0.64 Per Share, vs. FactSet Est of $-0.71 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Earnings Flash (ROIV) Roivant Sciences Reports Q4 Revenue $7.6M, vs. FactSet Est of $54.1M - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright maintains $18 target on Roivant Sciences stock - Investing.com Australia

May 29, 2025
pulisher
May 29, 2025

Roivant Sciences (NASDAQ:ROIV) Receives “Buy” Rating from HC Wainwright - Defense World

May 29, 2025
pulisher
May 28, 2025

H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock - MSN

May 28, 2025
pulisher
May 28, 2025

Roivant Staying ‘Patient’ On Deals, Leaving Investors Waiting - insights.citeline.com

May 28, 2025
pulisher
May 28, 2025

Roivant Sciences's Earnings Outlook - Nasdaq

May 28, 2025
pulisher
May 28, 2025

What To Expect From Roivant Sciences Ltd (ROIV) Q4 2025 Earnings - GuruFocus

May 28, 2025
pulisher
May 28, 2025

H.C. Wainwright maintains $18 target on Roivant Sciences stock By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Roivant Sciences (ROIV) Receives Reiterated Buy Rating from HC W - GuruFocus

May 28, 2025
pulisher
May 25, 2025

Ameriprise Financial Inc. Lowers Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World

May 25, 2025
pulisher
May 24, 2025

(ROIV) Investment Analysis and Advice - news.stocktradersdaily.com

May 24, 2025
pulisher
May 22, 2025

Roivant Sciences (ROIV) Projected to Post Quarterly Earnings on Thursday - Defense World

May 22, 2025
pulisher
May 21, 2025

IMVT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into a Private Placement Transaction by Immunovant, Inc. and Encourages Investors to Contact the Firm - FinancialContent

May 21, 2025
pulisher
May 20, 2025

Bank of America Corp DE Cuts Stake in Roivant Sciences Ltd. (NASDAQ:ROIV) - Defense World

May 20, 2025
pulisher
May 16, 2025

Don't Ignore The Insider Selling In Roivant Sciences - simplywall.st

May 16, 2025
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
Capitalizzazione:     |  Volume (24 ore):